Published in PLoS One on November 25, 2015
A METHYLATION-TO-EXPRESSION FEATURE MODEL FOR GENERATING ACCURATE PROGNOSTIC RISK SCORES AND IDENTIFYING DISEASE TARGETS IN CLEAR CELL KIDNEY CANCER. Pac Symp Biocomput (2016) 0.75
Decreased microRNA-452 expression and its prognostic significance in human osteosarcoma. World J Surg Oncol (2016) 0.75
Correction: Comparison of the Prognostic Utility of Diverse Molecular Data among lncRNA, DNA Methylation, microRNA and mRNA across Five Human Cancers. PLoS One (2016) 0.75
Downregulation of miR-154 in human glioma and its clinicopathological and prognostic significance. J Int Med Res (2016) 0.75
Gene expression profiling predicts clinical outcome of breast cancer. Nature (2002) 71.36
Integrated genomic analyses of ovarian carcinoma. Nature (2011) 47.72
Comprehensive molecular portraits of human breast tumours. Nature (2012) 47.39
Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med (1996) 46.18
Comprehensive molecular characterization of human colon and rectal cancer. Nature (2012) 34.13
Comprehensive genomic characterization of squamous cell lung cancers. Nature (2012) 18.90
Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature (2013) 13.60
Comprehensive molecular characterization of gastric adenocarcinoma. Nature (2014) 11.93
An overview of statistical learning theory. IEEE Trans Neural Netw (1999) 9.21
Comprehensive molecular characterization of urothelial bladder carcinoma. Nature (2014) 8.48
Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. J Natl Cancer Inst (2006) 8.38
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol (2010) 7.08
Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer (2005) 6.46
Prognostically relevant gene signatures of high-grade serous ovarian carcinoma. J Clin Invest (2012) 3.64
Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer. Nat Struct Mol Biol (2013) 2.84
Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res (2008) 2.75
The landscape of kinase fusions in cancer. Nat Commun (2014) 2.48
Modeling precision treatment of breast cancer. Genome Biol (2013) 2.42
GeneSrF and varSelRF: a web-based tool and R package for gene selection and classification using random forest. BMC Bioinformatics (2007) 2.06
Enabling transparent and collaborative computational analysis of 12 tumor types within The Cancer Genome Atlas. Nat Genet (2013) 1.80
Assessing the clinical utility of cancer genomic and proteomic data across tumor types. Nat Biotechnol (2014) 1.71
Gene co-expression network analysis reveals common system-level properties of prognostic genes across cancer types. Nat Commun (2014) 1.34
The lasso--a novel method for predictive covariate model building in nonlinear mixed effects models. J Pharmacokinet Pharmacodyn (2007) 1.17
Proportional hazards (Cox) regression. J Gen Intern Med (1993) 1.14
Translating cancer 'omics' to improved outcomes. Genome Res (2012) 1.07
Identification of properties important to protein aggregation using feature selection. BMC Bioinformatics (2013) 1.00
DNA methylation as clinically useful biomarkers-light at the end of the tunnel. Pharmaceuticals (Basel) (2012) 0.99
Aberrant transcriptional regulations in cancers: genome, transcriptome and epigenome analysis of lung adenocarcinoma cell lines. Nucleic Acids Res (2014) 0.98
High-throughput identification of reference genes for research and clinical RT-qPCR analysis of breast cancer samples. J Clin Bioinforma (2013) 0.96
Predicting the lethal phenotype of the knockout mouse by integrating comprehensive genomic data. Bioinformatics (2012) 0.91
On the reproducibility of TCGA ovarian cancer microRNA profiles. PLoS One (2014) 0.90
Combining clinicopathological predictors and molecular biomarkers in the oncogenic K-RAS/Ki67/HIF-1α pathway to predict survival in resectable pancreatic cancer. Br J Cancer (2015) 0.90
Detection of BRAF mutation in Chinese tumor patients using a highly sensitive antibody immunohistochemistry assay. Sci Rep (2015) 0.87
Comprehensive characterization of the genomic alterations in human gastric cancer. Int J Cancer (2014) 0.87
Comparison of immunohistochemistry assays and real-time reverse transcription-polymerase chain reaction for analyzing hormone receptor status in human breast carcinoma. Pathol Int (2010) 0.84
A novel approach to the discovery of survival biomarkers in glioblastoma using a joint analysis of DNA methylation and gene expression. Epigenetics (2014) 0.82
GMCT : a Monte Carlo simulation package for macromolecular receptors. J Comput Chem (2012) 0.81
Investigating Multi-cancer Biomarkers and Their Cross-predictability in the Expression Profiles of Multiple Cancer Types. Biomark Insights (2009) 0.81
Multi-state relative survival modelling of colorectal cancer progression and mortality. Cancer Epidemiol (2015) 0.78
RCM: a novel association approach to search for coronary artery disease genetic related metabolites based on SNPs and metabolic network. Genomics (2012) 0.78
Integrating multi-platform genomic data using hierarchical Bayesian relevance vector machines. EURASIP J Bioinform Syst Biol (2013) 0.78
Non-linear molecular pattern classification using molecular beacons with multiple targets. Biosystems (2013) 0.77
Connecting high-dimensional mRNA and miRNA expression data for binary medical classification problems. Comput Methods Programs Biomed (2013) 0.77